7 Nov 2017 FDA VRBPAC: Clinical development plan for a S. aureus vaccine (Part 1 of 3)
Addendum: This is the first in a 3-newsletters series on this topic. Go here and here for the next two newsletters. Finally, the results of the STRIVE trial have been published as Hassanzadeh et al. in Clinical Infectious Diseases, ciad218, https://doi.org/10.1093/cid/ciad218. Dear All: I just learned that FDA’s Vaccines and Related Biological Products Committee (VRBPAC) will meet at